Joy A. Adetunji

Joy A. Adetunji

Auto-generated profile, based on publicly available information

Joy A. Adetunji

Nutritional and Industrial Biochemistry Unit, Department of Biochemistry, College of Medicine, University of Ibadan, Nigeria

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2023 in Heliyon
Verified
Journal Article
Open access
JAJoy A. Adetunji
Joy A. Adetunji
KFKehinde D. Fasae
Kehinde D. Fasae
AAAyobami I. Awe
Ayobami I. Awe
OPOluwatomiwa K. Paimo
Oluwatomiwa K. Paimo
AAAyodeji M. Adegoke
Ayodeji M. Adegoke
MSMamello P. Sekhoacha
Mamello P. Sekhoacha
The endothelial cells (ECs) make up the inner lining of blood vessels, acting as a barrier separating the blood and the tissues in several organs. ECs maintain endothelium integrity by controlling the constriction and relaxation of the vasculature, blood fluidity, adhesion, and migration. These actions of ECs are efficiently coordinated via an intricate signaling network connecting receptors, and a wide range of cellular macromolecules. ECs are naturally quiescent i.e.; they are not stimulated and do not proliferate. Upon infection or disease, ECs become activated, and this alteration is pivotal in the pathogenesis of a spectrum of human neurological, cardiovascular, diabetic, cancerous, and viral diseases. Considering the central position that ECs play in disease pathogenesis, therapeutic options have been targeted at improving ECs integrity, assembly, functioning, and health. The dietary intake of flavonoids present in citrus fruits has been associated with a reduced risk of endothelium dysfunction. Naringenin (NGN) and Naringin (NAR), major flavonoids in grapefruit, tomatoes, and oranges possess anti-inflammatory, antioxidant properties, and cell survival potentials, which improve the health of the vascular endothelium. In this review, we provide a comprehensive summary and present the advances in understanding of the mechanisms through which NGN and NAR modulate the biomarkers of vascular dysfunction and protect the endothelium against unresolved inflammation, oxidative stress, atherosclerosis, and angiogenesis. We also provide perspectives and suggest further studies that will help assess the efficacy of citrus flavonoids in the therapeutics of human vascular diseases.

1 January 2023 in Bioinformatics Advances
Verified
Journal Article
Open access
PDF file
JAJoy A Adetunji
Joy A Adetunji
OOOludare Michael Ogunyemi
Oludare Michael Ogunyemi
GGGideon Gyebi
Gideon Gyebi
AAAnuoluwapo E Adewumi
Anuoluwapo E Adewumi
COCharles O Olaiya
Charles O Olaiya
Beta vulgaris (beet) is extensively reported for its antihypertensive activity. However, the mechanismunderpinning its antihypertensive activity is not well understood. In this study, we evaluated the in silico interactionsof 70 compounds derived from beta vulgaris against the active sites of angiotensin-converting enzyme (ACE) and alpha-adrenergic receptor (AR). Structure-based virtual screening against angiotensin-converting enzyme revealed that, Cochliophilin A (−9.0 Kcal/mol), Miraxanthin (−8.3 Kcal/mol), and quercimeritrin (−9.7 Kcal/mol) had lower docking scores than the reference lisinopril (−7.9 Kcal/mol). These compounds exhibited dual binding tendency as they also ranked top compounds upon screening against adrenergic receptor. The thermodynamic parameters computed from the resulting trajectories obtained from the 100 ns full atomistic molecular dynamics simulation revealed structural stability and conformational flexibility of the ligand–receptor complexes as indicated by the RMSD, RMSF, RoG, SASA, and H-bond calculations. The molecular mechanics with generalized Born and surface area solvation binding energy calculations revealed that the proteins exhibit considerable binding energy with the phytochemicals in a dynamic environment. Furthermore, the hit compounds possess good physicochemical properties and drug-likeness. Overall, cochliophilin and quercimeritrin are promising dual-target directed flavonoids from Beta vulgaris; and are suggested for further experimental and preclinical evaluation. All data was provided in the manuscript.